Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome

Mise à jour : Il y a 5 ans
Référence : NCT00110422

Femme et Homme

Extrait

The purpose of this clinical research study is to learn if irbesartan is superior to hydrochlorothiazide relative to effects on insulin sensitivity and glucose metabolism in hypertensive patients with metabolic syndrome.


Critère d'inclusion

  • Metabolic syndrome ,Hypertension


Liens